PD-L1 Immunohistochemical Detection in Tumor Cells and Tumor Microenvironment: Main Considerations on the Use of Tissue Micro Arrays
Overview
Chemistry
Molecular Biology
Affiliations
PD-1/PD-L1 (programmed death 1/programmed death ligand 1) pathway plays a critical role in immune escape of tumor cells. Recent studies have described that PD-L1 is heterogeneously expressed in various types of cancer, although its prognostic/predictive value is still uncertain. These problems are partly due to a not well defined operating protocol for its detection by immunohistochemistry, but also because most of the studies conducted on large case series were made by Tissue Micro Array (TMA). We are going to discuss this latter point, to highlight that TMA must be set up in an appropriate manner, especially for some markers, such as PD-L1, which, besides being poorly expressed in tumor cells, can be expressed by cells of the tumor microenvironment.
Tissue microarray validation in cervical carcinoma studies. A methodological approach.
Lovane L, Carrilho C, Karlsson C Histol Histopathol. 2024; 40(3):317-325.
PMID: 39086316 DOI: 10.14670/HH-18-796.
Pena-Cardelles J, Pozo-Kreilinger J, Roncador G, Esteban-Hernandez J, Moro-Rodriguez J, Sastre-Perona A Biomedicines. 2022; 10(3).
PMID: 35327512 PMC: 8945047. DOI: 10.3390/biomedicines10030710.
Wei X, Luo X, Sheng H, Wang Y, Chen D, Li J J Transl Med. 2020; 18(1):475.
PMID: 33308232 PMC: 7730753. DOI: 10.1186/s12967-020-02636-x.
Minopoli M, Botti G, Gigantino V, Ragone C, Sarno S, Motti M J Exp Clin Cancer Res. 2019; 38(1):459.
PMID: 31703596 PMC: 6839174. DOI: 10.1186/s13046-019-1465-8.
Lee A, Chew W, Wilding C, Guljar N, Smith M, Strauss D Sci Rep. 2019; 9(1):14602.
PMID: 31601875 PMC: 6787212. DOI: 10.1038/s41598-019-50888-5.